Characterization of the Binding and Inhibition Mechanisms of a Novel Neutralizing Monoclonal Antibody Targeting the Stem Helix Region in the S2 Subunit of the Spike Protein of SARS-CoV-2
Background/Objectives: For viral entry into host cells, the spike (S) protein of coronavirus (CoV) uses its S1 domain to bind to the host receptor and S2 domain to mediate the fusion between virion and cellular membranes. The S1 domain acquired multiple mutations as the severe acute respiratory synd...
| Published in: | Vaccines |
|---|---|
| Main Authors: | Selene Si Ern Tan, Ee Hong Tam, Kah Man Lai, Yanjun Wu, Tianshu Xiao, Yee-Joo Tan |
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-06-01
|
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-393X/13/7/688 |
Similar Items
The Emergence of Escape Mutations in COVID-19 Following Anti-Spike Monoclonal Antibody Treatment: How Do We Tackle It?
by: Focosi D, et al.
Published: (2025-10-01)
by: Focosi D, et al.
Published: (2025-10-01)
Neutralizing Monoclonal Anti-SARS-CoV-2 Antibodies Isolated from Immunized Rabbits Define Novel Vulnerable Spike-Protein Epitope
by: Efi Makdasi, et al.
Published: (2021-03-01)
by: Efi Makdasi, et al.
Published: (2021-03-01)
Fever temperatures modulate intraprotein dynamics and enhance the binding affinity between monoclonal antibodies and the spike protein from SARS-CoV-2
by: Dong Gun Kim, et al.
Published: (2022-01-01)
by: Dong Gun Kim, et al.
Published: (2022-01-01)
Characterization of two neutralizing monoclonal antibodies with conformational epitopes against porcine deltacoronavirus
by: Wan Lu, et al.
Published: (2025-01-01)
by: Wan Lu, et al.
Published: (2025-01-01)
First Case of COVID-19 Treated with Monoclonal Anti-Spike Antibodies in a Patient with Cystic Fibrosis in Romania
by: Iustina Violeta Stan, et al.
Published: (2022-01-01)
by: Iustina Violeta Stan, et al.
Published: (2022-01-01)
Development of the TSR-based computational method to investigate spike and monoclonal antibody interactions
by: Tarikul I. Milon, et al.
Published: (2025-03-01)
by: Tarikul I. Milon, et al.
Published: (2025-03-01)
Breakthroughs in SARS-CoV-2-monoclonal antibodies development
by: Yusuf Muhammed, et al.
Published: (2021-02-01)
by: Yusuf Muhammed, et al.
Published: (2021-02-01)
Spike S2 Subunit: The Dark Horse in the Race for Prophylactic and Therapeutic Interventions against SARS-CoV-2
by: Kim Tien Ng, et al.
Published: (2021-02-01)
by: Kim Tien Ng, et al.
Published: (2021-02-01)
Rabbit Monoclonal Antibody Specifically Recognizing a Linear Epitope in the RBD of SARS-CoV-2 Spike Protein
by: Junping Hong, et al.
Published: (2021-07-01)
by: Junping Hong, et al.
Published: (2021-07-01)
New Monoclonal Antibodies Specific for Different Epitopes of the Spike Protein of SARS-CoV-2 and Its Major Variants: Additional Tools for a More Specific COVID-19 Diagnosis
by: Sabrina Mariotti, et al.
Published: (2023-02-01)
by: Sabrina Mariotti, et al.
Published: (2023-02-01)
Novel Neutralizing Epitope of PEDV S1 Protein Identified by IgM Monoclonal Antibody
by: Techit Thavorasak, et al.
Published: (2022-01-01)
by: Techit Thavorasak, et al.
Published: (2022-01-01)
A Web Tool to Estimate Baseline Anti-Spike Monoclonal Antibody Efficacy Based on Regional Genomic Surveillance
by: Daniele Focosi
Published: (2023-04-01)
by: Daniele Focosi
Published: (2023-04-01)
Identification of conserved linear epitopes in the SARS-CoV-2 receptor-binding region using monoclonal antibodies
by: Yujie Yang, et al.
Published: (2023-06-01)
by: Yujie Yang, et al.
Published: (2023-06-01)
Production and Characterization of a Monoclonal Antibody Neutralizing Poliovirus Type 2
by: Morteza Kamalzadeh, et al.
Published: (2019-09-01)
by: Morteza Kamalzadeh, et al.
Published: (2019-09-01)
Spike Gene Evolution and Immune Escape Mutations in Patients with Mild or Moderate Forms of COVID-19 and Treated with Monoclonal Antibodies Therapies
by: Aude Jary, et al.
Published: (2022-01-01)
by: Aude Jary, et al.
Published: (2022-01-01)
Susceptibility of SARS-CoV-2 Omicron Variants to Therapeutic Monoclonal Antibodies: Systematic Review and Meta-analysis
by: Kaiming Tao, et al.
Published: (2022-08-01)
by: Kaiming Tao, et al.
Published: (2022-08-01)
Research Progress on Spike-Dependent SARS-CoV-2 Fusion Inhibitors and Small Molecules Targeting the S2 Subunit of Spike
by: Matthew R. Freidel, et al.
Published: (2024-04-01)
by: Matthew R. Freidel, et al.
Published: (2024-04-01)
Clinical Impact of Monoclonal Antibodies in the Treatment of High-Risk Patients with SARS-CoV-2 Breakthrough Infections: The ORCHESTRA Prospective Cohort Study
by: Alessia Savoldi, et al.
Published: (2022-08-01)
by: Alessia Savoldi, et al.
Published: (2022-08-01)
Resistance of SARS-CoV-2 Omicron BA.1 and BA.2 Variants to Vaccine-Elicited Sera and Therapeutic Monoclonal Antibodies
by: Hao Zhou, et al.
Published: (2022-06-01)
by: Hao Zhou, et al.
Published: (2022-06-01)
Spike-specific T-cell responses in patients with COVID-19 successfully treated with neutralizing monoclonal antibodies against SARS-CoV-2
by: Salvatore Rotundo, et al.
Published: (2022-11-01)
by: Salvatore Rotundo, et al.
Published: (2022-11-01)
Inference of nonlinear receptive field subunits with spike-triggered clustering
by: Nishal P Shah, et al.
Published: (2020-03-01)
by: Nishal P Shah, et al.
Published: (2020-03-01)
Spike S2 Subunit: Possible Target for Detecting Novel SARS-CoV-2 Variants with Multiple Mutations
by: Teerada Ponpinit, et al.
Published: (2024-02-01)
by: Teerada Ponpinit, et al.
Published: (2024-02-01)
SARS-CoV-2 spike protein S1 subunit induces potent neutralizing responses in mice and is effective against Delta and Omicron variants
by: Tarlan Mamedov, et al.
Published: (2023-11-01)
by: Tarlan Mamedov, et al.
Published: (2023-11-01)
Immunoglobulin Y Specific for SARS-CoV-2 Spike Protein Subunits Effectively Neutralizes SARS-CoV-2 Infectivity and Ameliorates Disease Manifestations In Vivo
by: Chia-Tsui Yeh, et al.
Published: (2022-11-01)
by: Chia-Tsui Yeh, et al.
Published: (2022-11-01)
SARS-CoV-2 spike S2-specific neutralizing antibodies
by: Chia-Jung Li, et al.
Published: (2023-12-01)
by: Chia-Jung Li, et al.
Published: (2023-12-01)
Evaluation of SARS-CoV-2 Serological Testing in Patients with Multiple Myeloma and Other Hematologic Malignancies on Monoclonal Antibody Therapies
by: Lenin Mahimainathan, et al.
Published: (2020-11-01)
by: Lenin Mahimainathan, et al.
Published: (2020-11-01)
Synthetic data-driven overlapped neural spikes sorting: decomposing hidden spikes from overlapping spikes
by: Min-Ki Kim, et al.
Published: (2024-11-01)
by: Min-Ki Kim, et al.
Published: (2024-11-01)
The Deleterious Effects of Shiga Toxin Type 2 Are Neutralized In Vitro by FabF8:Stx2 Recombinant Monoclonal Antibody
by: Daniela Luz, et al.
Published: (2021-11-01)
by: Daniela Luz, et al.
Published: (2021-11-01)
Evaluation of Inhibitory Activity In Silico of In-House Thiomorpholine Compounds between the ACE2 Receptor and S1 Subunit of SARS-CoV-2 Spike
by: Victor H. Vázquez-Valadez, et al.
Published: (2021-09-01)
by: Victor H. Vázquez-Valadez, et al.
Published: (2021-09-01)
Immune response to SARS-CoV-2 mRNA vaccination and booster dose in patients with multiple myeloma and monoclonal gammopathies: impact of Omicron variant on the humoral response
by: Paola Storti, et al.
Published: (2022-12-01)
by: Paola Storti, et al.
Published: (2022-12-01)
Immunogenicity and Neutralizing Activity Comparison of SARS-CoV-2 Spike Full-Length and Subunit Domain Proteins in Young Adult and Old-Aged Mice
by: Ki-Hye Kim, et al.
Published: (2021-03-01)
by: Ki-Hye Kim, et al.
Published: (2021-03-01)
Characterization of a neutralizing antibody that recognizes a loop region adjacent to the receptor-binding interface of the SARS-CoV-2 spike receptor-binding domain
by: Itsuki Anzai, et al.
Published: (2024-04-01)
by: Itsuki Anzai, et al.
Published: (2024-04-01)
SARS-CoV-2-induced phosphorylation and its pharmacotherapy backed by artificial intelligence and machine learning
by: Fouzia Qamar, et al.
Published: (2024-01-01)
by: Fouzia Qamar, et al.
Published: (2024-01-01)
Single monoclonal spike characterized as double monoclonal gammopathy in a patient with multiple myeloma: A rare finding
by: Rajni Saijpaul, et al.
Published: (2023-01-01)
by: Rajni Saijpaul, et al.
Published: (2023-01-01)
Detection of SARS-CoV-2 Nucleocapsid, Spike, and Neutralizing Antibodies in Vaccinated Japanese
by: Rie Midorikawa, et al.
Published: (2022-05-01)
by: Rie Midorikawa, et al.
Published: (2022-05-01)
Impaired potency of neutralizing antibodies against cell–cell fusion mediated by SARS-CoV-2
by: Qian Wang, et al.
Published: (2023-12-01)
by: Qian Wang, et al.
Published: (2023-12-01)
Proinflammatory Responses in SARS-CoV-2 and Soluble Spike Glycoprotein S1 Subunit Activated Human Macrophages
by: Kim Chiok, et al.
Published: (2023-03-01)
by: Kim Chiok, et al.
Published: (2023-03-01)
Acute lung injury induced by recombinant SARS-CoV-2 spike protein subunit S1 in mice
by: Jiwei Zhu, et al.
Published: (2025-02-01)
by: Jiwei Zhu, et al.
Published: (2025-02-01)
The Case for S2: The Potential Benefits of the S2 Subunit of the SARS-CoV-2 Spike Protein as an Immunogen in Fighting the COVID-19 Pandemic
by: Priyanka Shah, et al.
Published: (2021-03-01)
by: Priyanka Shah, et al.
Published: (2021-03-01)
Biodistribution and elimination kinetics of systemic Stx2 by the Stx2A and Stx2B subunit-specific human monoclonal antibodies in mice
by: Sheoran Abhineet, et al.
Published: (2012-06-01)
by: Sheoran Abhineet, et al.
Published: (2012-06-01)
Similar Items
-
The Emergence of Escape Mutations in COVID-19 Following Anti-Spike Monoclonal Antibody Treatment: How Do We Tackle It?
by: Focosi D, et al.
Published: (2025-10-01) -
Neutralizing Monoclonal Anti-SARS-CoV-2 Antibodies Isolated from Immunized Rabbits Define Novel Vulnerable Spike-Protein Epitope
by: Efi Makdasi, et al.
Published: (2021-03-01) -
Fever temperatures modulate intraprotein dynamics and enhance the binding affinity between monoclonal antibodies and the spike protein from SARS-CoV-2
by: Dong Gun Kim, et al.
Published: (2022-01-01) -
Characterization of two neutralizing monoclonal antibodies with conformational epitopes against porcine deltacoronavirus
by: Wan Lu, et al.
Published: (2025-01-01) -
First Case of COVID-19 Treated with Monoclonal Anti-Spike Antibodies in a Patient with Cystic Fibrosis in Romania
by: Iustina Violeta Stan, et al.
Published: (2022-01-01)
